Publication

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma

Related publications (33)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma

Graph Chatbot

Chat with Graph Search

6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice

TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma

Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progression

Immunomodulatory Roles of Lymphatic Vessels in Cancer Progression

Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response

Targeting and Modulating Tumor-Associated Sites with Novel Nanoparticle-Based Immunotherapies

Therapeutic Immunomodulation of the Lymphoid-like Tumor Environment Using Nanoparticulate Formulations

VEGF-C Promotes Immune Tolerance in B16 Melanomas and Cross-Presentation of Tumor Antigen by Lymph Node Lymphatics

Immune Engineering Via Differential Antigen Carriers and Co-Stimulatory Molecules

High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome